Shenfu injection for septic shock patients
Treatments studied
Part of Infections clinical trials.
This trial tests whether an herbal medicine called Shenfu Injection can improve blood flow regulation in patients with septic shock. It aims to help stabilize blood pressure and might reduce the need for vasopressors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must be diagnosed with septic shock, and your blood pressure must still be low enough that you need a medicine called norepinephrine (a vasopressor).
- You must be in the intensive care unit (ICU) and have been there for less than 24 hours.
- You must be on a breathing machine (ventilator) with a breathing tube and be sedated.
- You must have both an arterial line and a central venous catheter (tubes placed in your blood vessels to monitor you).
- Your doctor must confirm that you do not have a primary heart failure condition or other exclusions like pregnancy or severe lung issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether Shenfu injection can help prevent heart muscle damage in people with septic shock. If you have septic shock, you may be able to join this study to see if this treatment helps protect your heart.
This study tests whether a traditional Chinese medicine called Shenfu injection can improve the flexibility of the carotid artery in people with sepsis or septic shock. It may help doctors understand if this treatment can reduce complications from severe infections.
This study tests a medication called anisodamine to see if it can improve blood flow in tiny blood vessels under the tongue in people with septic shock. This might help their organs work better and make them recover faster.
This trial tests a blood-filtering device (CytoSorb) that may help control the overwhelming immune response and improve blood vessel function in people with severe septic shock. It's for patients who need strong medications to keep their blood pressure up and who haven't improved with standard care.
This trial tests a new approach to treating septic shock, a life-threatening condition where infection causes dangerously low blood pressure. It aims to see if a different way of managing fluids and medications can improve recovery compared to standard care.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.